International Journal of Cancer · 2018 · 52 citations · 25 references
MedicineOncologyUrologyCancer EpidemiologyEpidemiologic MethodsUrologic OncologyBiomarkers In Genitourinary CancerBladder CancerCancer RiskGenitourinary Cancer EpidemiologySex Differences In HealthBladder Cancer IncidenceCancer Epidemiology By SexCohort Study InvestigationDisease Severity EstimationDisease Severity IndexRiskTumor Cell InvasivenessUrothelial Carcinoma Epidemiology
Previous studies on metabolic factors and bladder cancer (BC) risk have shown inconsistent results and have commonly not investigated associations separately by sex, smoking, and tumor invasiveness. Among 811,633 participants in six European cohorts, we investigated sex‐specific associations between body mass index (BMI), mid‐blood pressure (BP, [systolic + diastolic]/2), plasma glucose, triglycerides, total cholesterol and risk of BC overall, non‐muscle invasive BC (NMIBC) and muscle invasive BC (MIBC). Among men, we additionally assessed additive interactions between metabolic factors and smoking on BC risk. During follow‐up, 2,983 men and 754 women were diagnosed with BC. Among men, triglycerides and BP were positively associated with BC risk overall (hazard ratio [HR] per standard deviation [SD]: 1.17 [95% confidence interval (CI) 1.06–1.27] and 1.09 [1.02–1.17], respectively), and among women, BMI was inversely associated with risk (HR: 0.90 [0.82–0.99]). The associations for BMI and BP differed between men and women ( p interaction ≤ 0.005). Among men, BMI, cholesterol and triglycerides were positively associated with risk for NMIBC (HRs: 1.09 [95% CI 1.01–1.18], 1.14 [1.02–1.25], and 1.30 [1.12–1.48] respectively), and BP was positively associated with MIBC (HR: 1.23 [1.02–1.49]). Among women, glucose was positively associated with MIBC (HR: 1.99 [1.04–3.81]). Apart from cholesterol, HRs for metabolic factors did not significantly differ between MIBC and NMIBC, and there were no interactions between smoking and metabolic factors on BC. Our study supports an involvement of metabolic aberrations in BC risk. Whilst some associations were significant only in certain sub‐groups, there were generally no significant differences in associations by smoking or tumor invasiveness.
25
K. G. M. M. Alberti, Paul Zimmet · Diabetic Medicine · 1998 · 15.3K citations
Body Fatness and Cancer — Viewpoint of the IARC Working Group
Béatrice Secretan, Chiara Scoccianti, Dana Loomis et al. · New England Journal of Medicine · 2016 · 3.5K citations · Full text
Medicine, Cancer Biology, Oncology +14